Skip to main content
. 2011 Oct 19;9(10):2010–2035. doi: 10.3390/md9102010

Figure 16.

Figure 16

Adjuvant activity assay with the lead 2-AIT, SPAR (30), and tobramycin against Pseudomonas aeruginosa PDO300. Shows that tobramycin and 2-AIT alone are not effective against PDO300, but combined the 2-AIT makes PDO300 more susceptible to tobramycin [83].